Answers are grounded in this paper and cite their sources.
Against the background of comorbidity in elderly patients, non-alcoholic fatty liver disease, especially its initial stage - fatty hepatosis, often does not attract due attention from therapists. Meanwhile, non-alcoholic fatty liver disease, in addition to severe outcomes, including cirrhosis, is dangerous due to its close pathogenetic relationship with insulin resistance, atherosclerosis and diabetes mellitus. This paper discusses the etiology, pathogenesis, and morphological changes in non-alcoholic fatty liver disease in elderly patients.
No takes yet. Share an insight, caveat, or question.
Георгиевич et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: